Clinical utility of comprehensive genomic profiling versus Oncomine Dx target test in pathological stage II-III non-small cell lung cancer.
- DOI
- 10.1038/s41598-025-21559-5
- Published
- 2025 Oct 27
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-025-21559-5,
title = {Clinical utility of comprehensive genomic profiling versus Oncomine Dx target test in pathological stage II-III non-small cell lung cancer.},
author = {Yano K and Kaseda K and Nakamura K and Okubo Y and Masai K and Hishida T and Nukaga S and Ohgino K and Terai H and Yasuda H and Kurebayashi Y and Fukunaga K and Nishihara H and Asakura K},
year = {2025},
journal = {Scientific reports},
doi = {10.1038/s41598-025-21559-5},
url = {https://doi.org/10.1038/s41598-025-21559-5}
}RIS
TY - JOUR TI - Clinical utility of comprehensive genomic profiling versus Oncomine Dx target test in pathological stage II-III non-small cell lung cancer. AU - Yano K AU - Kaseda K AU - Nakamura K AU - Okubo Y AU - Masai K AU - Hishida T AU - Nukaga S AU - Ohgino K AU - Terai H AU - Yasuda H AU - Kurebayashi Y AU - Fukunaga K AU - Nishihara H AU - Asakura K PY - 2025 JO - Scientific reports DO - 10.1038/s41598-025-21559-5 UR - https://doi.org/10.1038/s41598-025-21559-5 ER -
APA
K, Y., K, K., K, N., Y, O., K, M., T, H., S, N., K, O., H, T., H, Y., Y, K., K, F., H, N., & K, A. (2025). Clinical utility of comprehensive genomic profiling versus Oncomine Dx target test in pathological stage II-III non-small cell lung cancer.. Scientific reports. https://doi.org/10.1038/s41598-025-21559-5
Source records
- pubmed · retrieved 2026-09-25T17:58:22.499Z